Literature DB >> 11719272

Analysis of heat shock transcription factor for suppression of polyglutamine toxicity.

M Rimoldi1, A Servadio, V Zimarino.   

Abstract

Individually over-expressed chaperones can interfere with cytotoxicity and aggregation of polyglutamine proteins in disease models. As chaperones cooperate, the analysis of suppression or reversal of polyglutamine pathology may require ways to up-regulate multiple chaperone coding genes. This condition might be achieved by exogenous expression of de-repressed forms of heat shock transcription factor 1 (HSF1), which mediates induction of several genes coding cytosolic and nuclear chaperones. Here we present the rationale behind this possible approach and the caveats, and employ a non-neuronal cell system to test whether Ataxin-1 aggregation can be modulated by de-repressed HSF1 mutants through augmented expression of chaperone coding genes. In our experiments, HSF1 mutants have induced heat shock protein 70 and Human DnaJ (HDJ)-1 to intermediate levels. Cells expressing such mutants also showed partial reduction of Ataxin-1 [31Q] aggregation. A consolidated positive outcome of these tests in cellular models would encourage experiments in transgenic mice and prospects for pharmacological modulation of HSF1 activity or delivery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719272     DOI: 10.1016/s0361-9230(01)00602-5

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  10 in total

Review 1.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

2.  Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease.

Authors:  Masahisa Katsuno; Chen Sang; Hiroaki Adachi; Makoto Minamiyama; Masahiro Waza; Fumiaki Tanaka; Manabu Doyu; Gen Sobue
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

Review 3.  Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.

Authors:  Antoni Matilla-Dueñas; Ivelisse Sánchez; Marc Corral-Juan; Antoni Dávalos; Ramiro Alvarez; Pilar Latorre
Journal:  Cerebellum       Date:  2010-06       Impact factor: 3.847

4.  Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration.

Authors:  Naohide Kondo; Masahisa Katsuno; Hiroaki Adachi; Makoto Minamiyama; Hideki Doi; Shinjiro Matsumoto; Yu Miyazaki; Madoka Iida; Genki Tohnai; Hideaki Nakatsuji; Shinsuke Ishigaki; Yusuke Fujioka; Hirohisa Watanabe; Fumiaki Tanaka; Akira Nakai; Gen Sobue
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  Hsp70 and its molecular role in nervous system diseases.

Authors:  Giuseppina Turturici; Gabriella Sconzo; Fabiana Geraci
Journal:  Biochem Res Int       Date:  2011-02-24

6.  Deciphering human heat shock transcription factor 1 regulation via post-translational modification in yeast.

Authors:  Liliana Batista-Nascimento; Daniel W Neef; Phillip C C Liu; Claudina Rodrigues-Pousada; Dennis J Thiele
Journal:  PLoS One       Date:  2011-01-06       Impact factor: 3.240

Review 7.  Barcoding heat shock proteins to human diseases: looking beyond the heat shock response.

Authors:  Vaishali Kakkar; Melanie Meister-Broekema; Melania Minoia; Serena Carra; Harm H Kampinga
Journal:  Dis Model Mech       Date:  2014-04       Impact factor: 5.758

Review 8.  Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies.

Authors:  Benjamin R Underwood; David C Rubinsztein
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

9.  Hsf1 activation inhibits rapamycin resistance and TOR signaling in yeast revealed by combined proteomic and genetic analysis.

Authors:  Sricharan Bandhakavi; Hongwei Xie; Brennon O'Callaghan; Hiroshi Sakurai; Do-Hyung Kim; Timothy J Griffin
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

10.  Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response.

Authors:  Yu-Qian Zhang; Kevin D Sarge
Journal:  J Mol Med (Berl)       Date:  2007-10-18       Impact factor: 4.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.